117 related articles for article (PubMed ID: 8205750)
41. Lactate and glucose exchange across the forearm, legs, and splanchnic bed during and after prolonged leg exercise.
Ahlborg G; Felig P
J Clin Invest; 1982 Jan; 69(1):45-54. PubMed ID: 7054242
[TBL] [Abstract][Full Text] [Related]
42. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways.
Baran K; Preston E; Wilks D; Cooney GJ; Kraegen EW; Sainsbury A
Diabetes; 2002 Jan; 51(1):152-8. PubMed ID: 11756335
[TBL] [Abstract][Full Text] [Related]
43. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise.
Wahren J; Sato Y; Ostman J; Hagenfeldt L; Felig P
J Clin Invest; 1984 May; 73(5):1367-76. PubMed ID: 6715541
[TBL] [Abstract][Full Text] [Related]
44. Neuropeptide Y (NPY) induced inhibition of preganglionic nerve stimulation evoked release of adrenalin and noradrenaline in the pithed rat.
Dahlöf P; Persson K; Lundberg JM; Dahlöf C
Acta Physiol Scand; 1988 Jan; 132(1):51-7. PubMed ID: 2851918
[TBL] [Abstract][Full Text] [Related]
45. Splanchnic and extrasplanchnic extraction of insulin following oral and intravenous glucose loads.
Brundin T
Clin Sci (Lond); 1999 Oct; 97(4):429-36. PubMed ID: 10491343
[TBL] [Abstract][Full Text] [Related]
46. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
47. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
48. Comparison of the hyperglycaemic and glycogenolytic responses to catecholamines with those to stimulation of the hepatic sympathetic innervation in the dog.
Edwards AV; Silver M
J Physiol; 1972 Jun; 223(2):571-93. PubMed ID: 5039287
[TBL] [Abstract][Full Text] [Related]
49. Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man.
Felig P; Wahren J; Hendler R
J Clin Invest; 1976 Sep; 58(3):761-5. PubMed ID: 956401
[TBL] [Abstract][Full Text] [Related]
50. Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat.
Marks JL; Waite K
J Neuroendocrinol; 1997 Feb; 9(2):99-103. PubMed ID: 9041362
[TBL] [Abstract][Full Text] [Related]
51. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man.
Pernow J; Lundberg JM; Kaijser L
Life Sci; 1987 Jan; 40(1):47-54. PubMed ID: 3796213
[TBL] [Abstract][Full Text] [Related]
52. Sympathetic drive to liver and nonhepatic splanchnic tissue during prolonged exercise is increased in diabetes.
Coker RH; Krishna MG; Zinker BA; Allen EJ; Lacy DB; Wasserman DH
Metabolism; 1997 Nov; 46(11):1327-32. PubMed ID: 9361694
[TBL] [Abstract][Full Text] [Related]
53. Splanchnic vasomotor and metabolic adjustments to hypoxia and exercise in humans.
Rowell LB; Blackmon JR; Kenny MA; Escourrou P
Am J Physiol; 1984 Aug; 247(2 Pt 2):H251-8. PubMed ID: 6465330
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the effects of neuropeptide Y and noradrenaline on rat gastric mucosal blood flow and integrity.
Tepperman BL; Whittle BJ
Br J Pharmacol; 1991 Jan; 102(1):95-100. PubMed ID: 2043936
[TBL] [Abstract][Full Text] [Related]
55. Adrenaline increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans.
Watt MJ; Howlett KF; Febbraio MA; Spriet LL; Hargreaves M
J Physiol; 2001 Jul; 534(Pt 1):269-78. PubMed ID: 11433007
[TBL] [Abstract][Full Text] [Related]
56. Effect of verapamil on basal and glucagon-dependent splanchnic glucose metabolism and insulin secretion in man.
Gasić S; Bratusch-Marrain P; Waldhäusl W; Korn A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):36-40. PubMed ID: 3042640
[TBL] [Abstract][Full Text] [Related]
57. Effect of synthetic porcine neuropeptide Y (NPY) on splanchnic blood flows and exocrine pancreatic secretion in dogs.
Sumi S; Inoue K; Kogire M; Doi R; Yun M; Kaji H; Hosotani R; Fujimura M; Uchida K; Kiyama S; Kitagawa K; Yajima H; Fujii N; Tobe T
Dig Dis Sci; 1991 Nov; 36(11):1523-8. PubMed ID: 19160602
[TBL] [Abstract][Full Text] [Related]
58. Effects of plasma adrenaline on hormone-sensitive lipase at rest and during moderate exercise in human skeletal muscle.
Watt MJ; Stellingwerff T; Heigenhauser GJ; Spriet LL
J Physiol; 2003 Jul; 550(Pt 1):325-32. PubMed ID: 12730334
[TBL] [Abstract][Full Text] [Related]
59. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
Clarke J; Benjamin N; Larkin S; Webb D; Maseri A; Davies G
Circulation; 1991 Mar; 83(3):774-7. PubMed ID: 1999028
[TBL] [Abstract][Full Text] [Related]
60. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis.
Brenard R; Moreau R; Pussard E; Champigneulle B; Gaudin C; Hadengue A; Braillon A; Lebrec D
J Hepatol; 1992 Mar; 14(2-3):347-56. PubMed ID: 1386858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
